Eris Lifesciences acquires 51 percent stake in Swiss Parenterals to expand its footprint in sterile injectables financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
Eris Lifesciences expands footprint in sterile injectables with acquisition of 51% stake in Swiss Parenterals biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Eris Lifesciences expands footprint in sterile injectables with acquisition of 51% stake in Swiss Parenterals biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Capri Global Capital Ltd announces Stock Split and 1:1 bonus aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], February 7: Board of directors of Capri Global Capital Ltd (CGCL), a diversified Non-Banking Financial Company (NBFC) with a presence across diverse segments like MSME, Affordable Housing, Construction Finance segments among others has approved stock split and 1:1 bonus issue. The company board also approved issuance of Non-Convertible Debentures through Public issue/private placement for an amount up to Rs. 500 crore in tranches. Business News | Capri Global Capital Ltd Announces Stock Split and 1:1 Bonus.